Abateas Industries Ltd Stock Price Today (NSE: ABATEAS)
Fundamental Score
Abateas Industries Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Abateas Industries Ltd share price today is ₹11.72, down 0.85% on NSE/BSE as of 20 April 2026. Abateas Industries Ltd (ABATEAS) is a Small-cap company in the Hospital sector with a market capitalisation of ₹263.20 (Cr). The 52-week high for ABATEAS share price is ₹26.20 and the 52-week low is ₹9.62. At a P/E ratio of 50.62x, ABATEAS is currently trading below its industry average P/E of 52.84x.
Abateas Industries Ltd Share Price Chart — NSE/BSE Historical Performance
Institutional Deep-Dive
Bull Run Research Hub
Abateas Share Price: A Financial Analysis for Industry Dominance
In the specialized healthcare sector, particularly within hospital services, the ability to efficiently manage capital allocation is paramount. This financial analysis delves into the current state of Abateas share price, presently trading at ₹10.819999694824219. A key consideration is the company's Price-to-Earnings (PE) ratio of 50.62, a metric indicating how much investors are willing to pay for each rupee of earnings. This suggests either high growth expectations or potential overvaluation compared to sector averages.
A significant concern arising from our 80-parameter fundamental audit, verified by Sweta Mishra, is the reported Return on Capital Employed (ROCE) of None%. ROCE measures how effectively a company generates profits from its capital. A ROCE of zero signals that Abateas is not currently generating any return on its invested capital, raising questions about its operational efficiency and capital management. This, in turn, weakens any potential economic moat the company might try to establish, as it becomes difficult to sustain competitive advantages without generating returns.
Comparing Abateas Industries Ltd with peers like
Nephro Care India Limited regarding management quality necessitates a deeper dive into operational metrics. While Nephro Care India Limited might demonstrate better capital allocation strategies and efficient use of resources, leading to a more robust financial performance, a comprehensive assessment of both companies' management teams and their track records is crucial. Differences in leadership experience, strategic decision-making, and operational execution can significantly impact their respective abilities to drive sustainable growth.The high PE ratio coupled with a None% ROCE paints a complex picture for Abateas share price. While the market may be pricing in future growth potential, the current lack of return on capital warrants caution. Further investigation into the underlying causes of the zero ROCE is essential. Observing future financial performance and monitoring improvements in capital efficiency will be key in determining the long-term sustainability of the current valuation. This analysis uses observable data points only and does not constitute financial advice.
Abateas Industries Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹11.47 | ₹11.50 | ₹10.92 | ₹11.28 | 30.53K (Cr) | |
| ₹10.95 | ₹11.50 | ₹10.63 | ₹11.13 | 52.91K (Cr) | |
| ₹11.52 | ₹11.52 | ₹11.00 | ₹11.10 | 44.33K (Cr) | |
| ₹11.55 | ₹11.70 | ₹11.21 | ₹11.53 | 46.82K (Cr) | |
| ₹11.75 | ₹11.79 | ₹11.23 | ₹11.79 | 27.13K (Cr) | |
| ₹11.16 | ₹11.41 | ₹10.51 | ₹11.23 | 67.81K (Cr) | |
| ₹11.03 | ₹11.98 | ₹10.85 | ₹10.87 | 44.80K (Cr) | |
| ₹11.59 | ₹12.00 | ₹11.22 | ₹11.42 | 12.14K (Cr) | |
| ₹12.69 | ₹12.69 | ₹11.53 | ₹11.59 | 15.75K (Cr) | |
| ₹11.62 | ₹12.13 | ₹11.10 | ₹12.13 | 34.42K (Cr) |
Abateas Industries Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹10.95 | ₹11.50 | ₹10.63 | ₹11.28 | +3.01% | |
| ₹11.91 | ₹12.69 | ₹10.51 | ₹11.10 | -6.80% | |
| ₹11.40 | ₹15.20 | ₹10.01 | ₹12.09 | +6.05% | |
| ₹18.48 | ₹19.59 | ₹11.70 | ₹11.71 | -36.63% | |
| ₹17.55 | ₹19.05 | ₹15.91 | ₹17.50 | -0.28% | |
| ₹16.50 | ₹20.11 | ₹16.04 | ₹17.57 | +6.48% | |
| ₹16.33 | ₹17.90 | ₹14.78 | ₹16.34 | +0.06% | |
| ₹15.47 | ₹20.75 | ₹15.47 | ₹16.33 | +5.56% | |
| ₹25.71 | ₹26.20 | ₹16.28 | ₹16.28 | -36.68% | |
| ₹14.20 | ₹25.27 | ₹14.20 | ₹25.21 | +77.60% | |
| ₹10.10 | ₹13.52 | ₹10.10 | ₹13.52 | +33.86% | |
| ₹9.62 | ₹10.10 | ₹9.62 | ₹10.10 | +4.99% |
AI Research Briefing
Powered by Gemini · 2026-04-17
Micro-cap hospital play with weak fundamentals and promoter games; avoid unless you like lighting money on fire.
⚡WHAT'S HAPPENING NOW (last 2-4 weeks):
Abateas Industries saw its investment rating upgraded from Strong Sell to Sell by MarketsMojo on April 7, 2026, citing technical improvements, though fundamental challenges persist. ASYA, a promoter group entity, acquired a 4.5% stake (70,92,291 shares) in an off-market transaction on March 23, 2026.
�� CORE STORY (THE REAL GAME):
Abateas is a micro-cap trying to ride the India hospital growth wave, but its small size and weak financials make it a risky bet. The promoter activity suggests some confidence, but the core business needs a major turnaround.
- Promoter group buying shares
- Technical upgrade from 'Strong Sell' to 'Sell'
- Healthcare sector tailwinds in India
- Significant order wins in hospital or education verticals
- Successful turnaround in profitability
- Major hospital acquisition
- Micro/SME cap = liquidity risk
- Weak profitability and ROE
- History of operational losses
Promoter increased stake by 4.5% (ASYA acquisition)
Indian healthcare sector is growing, but competition is intense.
Free Cash Flow 5Y: ₹None Cr - Profit not converting to cash.
3-6 month thesis: Monitor for signs of a genuine turnaround. Needs to demonstrate consistent profitability and cash flow. Avoid if it fails to deliver.
Primary Thesis Risk
Liquidity risk and weak fundamentals make this a potential zero.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Abateas Industries Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Shareholding Pattern
Promoter
FII
DII
Pledged
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Abateas Industries Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ABATEAS across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Robust Profit Growth (13666.67%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Conservative Debt Levels (D/E: 0.05)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (16.71x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Premium Valuation Risk (P/E: 50.62x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Low Promoter Commitment (27.56%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Peer Comparison - Hospital
Compare Abateas Industries Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Abateas Industries LtdAbateas Industr...Selected✓ ABATEAS • 531658 | 14.9/100 | ₹11.72₹12 | ₹263.20₹263.20 | 50.62Average 50.6 Average | 0.00%Poor 0.00% Poor | 0.00%Poor 0.00% Poor | 0.05Excellent 0.1 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Max Healthcare Institute LtdMax Healthcare ... MAXHEALTH • 543220 | 69.1/100 | ₹1011.60₹1012 | ₹109416.28₹109416.28 | 77.65Average 77.7 Average | 12.72%Average 12.72% Average | 0.00%Poor 0.00% Poor | 0.33Excellent 0.3 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Apollo Hospitals Enterprise LtdApollo Hospital... APOLLOHOSP • 508869 | 50.2/100 | ₹7664.00₹7664 | ₹104825.94₹104825.94 | 62.70Average 62.7 Average | 18.42%Good 18.42% Good | 0.00%Poor 0.00% Poor | 0.88Good 0.9 Good | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Fortis Healthcare LtdFortis Healthca... FORTIS • 532843 | 55.6/100 | ₹890.85₹891 | ₹68301.24₹68301.24 | 67.80Average 67.8 Average | 10.13%Average 10.13% Average | 0.00%Poor 0.00% Poor | 0.34Excellent 0.3 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Narayana Hrudayalaya LtdNarayana Hruday... NH • 539551 | 62.2/100 | ₹1808.60₹1809 | ₹39051.19₹39051.19 | 45.92Average 45.9 Average | 24.22%Excellent 24.22% Excellent | 0.00%Poor 0.00% Poor | 0.58Good 0.6 Good | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Aster DM Healthcare LtdAster DM Health... ASTERDM • 540975 | 15.4/100 | ₹684.50₹685 | ₹34688.15₹34688.15 | 94.51Average 94.5 Average | 8.26%Poor 8.26% Poor | 0.00%Poor 0.00% Poor | 0.46Excellent 0.5 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Global Health LtdGlobal Health L... MEDANTA • 543654 | 61/100 | ₹1082.25₹1082 | ₹33498.00₹33498.00 | 56.03Average 56.0 Average | 16.48%Good 16.48% Good | 0.00%Poor 0.00% Poor | 0.25Excellent 0.3 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
45.1/100 | ₹677.20₹677 | ₹27605.54₹27605.54 | 83.99Average 84.0 Average | 18.48%Good 18.48% Good | 0.00%Poor 0.00% Poor | 1.40Average 1.4 Average | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% | |
Dr Agarwals Health Care LtdDr Agarwals Hea... AGARWALEYE • 544350 | 51.2/100 | ₹446.00₹446 | ₹16844.04₹16844.04 | 145.15Average 145.2 Average | 4.76%Poor 4.76% Poor | 0.00%Poor 0.00% Poor | 0.51Good 0.5 Good | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Rainbow Childrens Medicare Pvt LtdRainbow Childre... RAINBOW • 543524 | 54.6/100 | ₹1255.00₹1255 | ₹13410.38₹13410.38 | 52.84Average 52.8 Average | 17.43%Good 17.43% Good | 0.00%Poor 0.00% Poor | 0.54Good 0.5 Good | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
36.4/100 | ₹562.70₹563 | ₹10474.40₹10474.40 | 296.22Average 296.2 Average | 5.14%Poor 5.14% Poor | 0.00%Poor 0.00% Poor | 1.92Average 1.9 Average | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% | |
Abateas Industries Ltd Financial Statements
Comprehensive financial data for Abateas Industries Ltd including income statement, balance sheet and cash flow
About ABATEAS (Abateas Industries Ltd)
Abateas Industries Ltd is a multifaceted healthcare entity making significant strides within hospital environments. Imagine stepping into a state-of-the-art eye clinic, where the p...recision of diagnostic equipment meets the compassionate care of specialized ophthalmologists. Abateas integrates seamlessly into this setting, providing advanced surgical tools for delicate procedures like cataract removal and laser vision correction. Their unwavering commitment to quality shines through in every aspect, from the sterile packaging of surgical instruments to the ergonomic design of examination chairs. Abateas also plays a pivotal role in equipping hospital pharmacies with a comprehensive range of ophthalmic medications and solutions, ensuring patients receive the treatments they need. Furthermore, Abateas invests heavily in continuous medical education for hospital staff, facilitating the seamless integration of new technologies and protocols. Within hospital infrastructure, Abateas extends its expertise beyond direct patient care. Their innovative architectural division collaborates with hospital administrators to design and optimize patient flow, maximizing efficiency and minimizing patient wait times. Consider the carefully planned layout of a new oncology ward, or the thoughtful redesign of an existing emergency department to enhance accessibility and functionality. Moreover, their business advisory team assists hospitals in navigating the complexities of healthcare finance and compliance, offering guidance on matters ranging from resource allocation to regulatory reporting. Abateas strives to be a trusted partner, working to make sure hospitals deliver the best possible patient outcomes within sustainable operational frameworks. Crucially, Abateas Industries Ltd acknowledges that comprehensive healthcare hinges on a holistic approach. To this end, their educational arm develops bespoke training programs for nurses, technicians, and other allied health professionals working in hospital settings. These programs emphasize practical skills, evidence-based practices, and the importance of patient-centered care. Think of the newly trained surgical nurse efficiently assisting in a complex cardiac operation, or the medical technician skillfully operating advanced imaging equipment. By investing in the professional growth of hospital staff, Abateas plays a crucial role in fostering a culture of excellence and continuous improvement within the wider healthcare ecosystem.
Company Details
Key Leadership
Latest News
ABATEAS Share Price: Frequently Asked Questions
What is the current share price of Abateas Industries Ltd?
As of 20 Apr 2026, 08:30 am IST, Abateas Industries Ltd share price is ₹11.72. The Abateas Industries Ltd stock has a market capitalisation of ₹263.20 (Cr) on NSE/BSE.
Is Abateas Industries Ltd share price Overvalued or Undervalued?
Abateas Industries Ltd share price is currently trading at a P/E ratio of 50.62x, compared to the industry average of 52.84x. Based on this relative valuation, the Abateas Industries Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of Abateas Industries Ltd share price?
The 52-week high of Abateas Industries Ltd share price is ₹26.20 and the 52-week low is ₹9.62. These values are updated daily from NSE/BSE price data.
What factors affect the Abateas Industries Ltd share price?
Key factors influencing Abateas Industries Ltd share price include quarterly earnings growth (Sales Growth: N/A%), raw material costs, government spending, and institutional flows (FII/DII holding).
Is Abateas Industries Ltd a good stock for long-term investment?
Abateas Industries Ltd shows a 5-year Profit Growth of N/A% and an ROE of N/A%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.05 before investing in Abateas Industries Ltd shares.
How does Abateas Industries Ltd compare with its industry peers?
Abateas Industries Ltd competes with major peers in the Hospital. Investors should compare Abateas Industries Ltd share price P/E of 50.62x and ROE of N/A% against the industry averages to determine competitive standing.
What is the P/E ratio of Abateas Industries Ltd and what does it mean?
Abateas Industries Ltd share price has a P/E ratio of 50.62x compared to the industry average of 52.84x. Investors pay ₹51 for every ₹1 of annual earnings.
How is Abateas Industries Ltd performing according to Bull Run's analysis?
Abateas Industries Ltd has a Bull Run fundamental score of 14.9/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does Abateas Industries Ltd belong to?
Abateas Industries Ltd operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Abateas Industries Ltd share price.
What is Return on Equity (ROE) and why is it important for ABATEAS?
ABATEAS has an ROE of N/A%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Abateas Industries Ltd generates profits from shareholders capital.
How is ABATEAS debt-to-equity ratio and what does it indicate?
ABATEAS has a debt-to-equity ratio of 0.05, which indicates conservative financing with low financial risk.
What is ABATEAS dividend yield and is it a good dividend stock?
ABATEAS offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Abateas Industries Ltd shares.
How has ABATEAS share price grown over the past 5 years?
ABATEAS has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in ABATEAS and why does it matter?
Promoters hold 27.56% of ABATEAS shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Abateas Industries Ltd.
What is ABATEAS market capitalisation category?
ABATEAS has a market capitalisation of ₹263 crores, placing it in the Small-cap category.
How volatile is ABATEAS stock?
ABATEAS has a beta of N/A. A beta > 1 suggests the Abateas Industries Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ABATEAS operating profit margin trend?
ABATEAS has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is ABATEAS quarterly performance?
Recent quarterly performance shows Abateas Industries Ltd YoY Sales Growth of N/A% and YoY Profit Growth of 13666.67%.
What is the institutional holding pattern in ABATEAS?
ABATEAS has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Abateas Industries Ltd stock.